PHARMA

S-IN has extensive experience in collaborating with R&D pharma researchers.
If you need support in any of these development steps for your pharmaceutical products: from design and drug optimization to lab management and risk assessment, we can help you.

Our areas of focus include:
· computer-assisted structure elucidation (CASE)
· chromatographic method development
· analytical chemistry informatics
· lab management
· quality by design and machine learning approaches applied to experimental design
· molecular modeling
· bibliographic researches
· toxicological risk assessment and genotoxicity impurities (GI) assessment
· in silico toxicological assessment of N-nitrosamines
· setting limits for Nitrosamines using in silico approaches, including carcinogenic potency categorization approach (CPCA) calculation and read- across
· impurity resolution management
· physicochemical, ADME and toxicity predictions
· consultancy
· training